SCHEMBL1090634

SCHEMBL1090634

O=C(CCc1ccccc1)N1CCCC(N2CCCCC(Nc3nccc(N4CCCCCC4)n3)C2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.54
KDM6B O15054 1/20 0.46
KDM5C P41229 1/20 0.46
KDM4C Q9H3R0 1/20 0.46
KDM2A Q9Y2K7 1/20 0.46
KDM3A Q9Y4C1 1/20 0.46
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 2/20 0.43
CCNK O75909 2/20 0.43
CDK12 Q9NYV4 2/20 0.43
GRIN2B Q13224 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
IDH1 O75874 2/20 0.42
GFER P55789 1/20 0.42
NPC1 O15118 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
OGA O60502 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090766 0.99 CXCR4 (0.55) CXCR4KDM6BKDM5CKDM4CKDM2A
SCHEMBL1090337 0.96 CXCR4 (0.57) CXCR4KDM6BKDM5CKDM4CKDM2A
SCHEMBL1090514 0.92 CXCR4 (0.56) CXCR4KDM5CKDM4CKDM2AALDH1A1
SCHEMBL1090827 0.92 CXCR4 (0.56) CXCR4KDM6BKDM5CKDM4CKDM2A
SCHEMBL1090872 0.92 CXCR4 (0.56) CXCR4KDM5CKDM4CKDM2AHPGD
SCHEMBL1090902 0.91 CXCR4 (0.57) CXCR4KDM6BKDM5CKDM4CKDM2A
SCHEMBL1091253 0.88 CCNK (0.49) CXCR4KDM6BKDM5CKDM4CKDM2A
SCHEMBL1091017 0.88 CXCR4 (0.52) CXCR4CCNKCDK12HRH4IDH1
SCHEMBL1091030 0.88 CXCR4 (0.46) CXCR4KDM4EMAPK1ALDH1A1CCNK
SCHEMBL1091176 0.88 CXCR4 (0.46) CXCR4KDM4EMAPK1ALDH1A1CCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM6B 2597/4885KDM5C 3193/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM6B 2597/4885KDM5C 3193/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885KDM6B 2597/4885KDM5C 3193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.